Combination Therapy With Tofacitinib Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis as Induction Therapy for Refractory Ulcerative Colitis

BACKGROUND: The use of monotherapy with intensive granulocyte and monocyte adsorptive apheresis (GMA) or a Janus kinase (JAK) inhibitor has been limited to patients with refractory ulcerative colitis (UC). The efficacy and safety of combination therapy with tofacitinib (TOF) plus intensive GMA (two...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanida, Satoshi, Ozeki, Keiji, Mizoshita, Tsutomu, Kitagawa, Mika, Ozeki, Takanori, Tanaka, Mamoru, Nishie, Hirotada, Shimura, Takaya, Kubota, Eiji, Kataoka, Hiromi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968921/
https://www.ncbi.nlm.nih.gov/pubmed/32010420
http://dx.doi.org/10.14740/jocmr4037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968921/
https://www.ncbi.nlm.nih.gov/pubmed/32010420
http://dx.doi.org/10.14740/jocmr4037

Ejemplares similares